BIOKEY: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
BIOKEY
Largest movements
- Receivables within one year -€3,686
down €3,686 (-73.7%), from €5,001 to €1,315
- Other debts +€32,573
up €32,573 (+33.8%), from €96,324 to €128,897
- Profit (loss) carried forward -€26,728
down €26,728 (-13.4%), from -€199,797 to -€226,525
- Trade debts -€9,497
down €9,497 (-100.0%), from €9,497 to €0
- Gross operating margin +€22,301
up €22,301 (+46.2%), from -€48,288 to -€25,987
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €5,582 | €1,931 | -€3,652 | -65.4% |
| Current assets | 29/58 | €5,582 | €1,931 | -€3,652 | -65.4% |
| Amounts receivable within one year | 40/41 | €5,001 | €1,315 | -€3,686 | -73.7% |
| Other amounts receivable | 41 | €5,001 | €1,315 | -€3,686 | -73.7% |
| Cash at bank and in hand | 54/58 | €581 | €616 | +€34 | +5.9% |
| Total equity and liabilities | 10/49 | €5,582 | €1,931 | -€3,652 | -65.4% |
| Equity | 10/15 | -€176,547 | -€203,275 | -€26,728 | -15.1% |
| Contributions | 10/11 | €23,250 | €23,250 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€199,797 | -€226,525 | -€26,728 | -13.4% |
| Amounts payable | 17/49 | €182,129 | €205,205 | +€23,076 | +12.7% |
| Amounts payable after more than one year | 17 | €76,308 | €76,308 | = | 0.0% |
| Other amounts payable | 178/9 | €76,308 | €76,308 | = | 0.0% |
| Amounts payable within one year | 42/48 | €105,821 | €128,897 | +€23,076 | +21.8% |
| Trade debts | 44 | €9,497 | €0 | -€9,497 | -100.0% |
| Suppliers | 440/4 | €9,497 | €0 | -€9,497 | -100.0% |
| Other amounts payable | 47/48 | €96,324 | €128,897 | +€32,573 | +33.8% |
| Accrued charges and deferred income | 492/3 | €0 | - | = | |
| Other operating charges | 640/8 | €531 | €698 | +€166 | +31.3% |
| Gross operating margin | 9900 | -€48,288 | -€25,987 | +€22,301 | +46.2% |
| Operating profit (loss) | 9901 | -€48,819 | -€26,684 | +€22,135 | +45.3% |
| Financial income | 75/76B | €0 | €0 | -€0 | -100.0% |
| Recurring financial income | 75 | €0 | €0 | -€0 | -100.0% |
| Financial charges | 65/66B | €46 | €44 | -€2 | -5.0% |
| Recurring financial charges | 65 | €46 | €44 | -€2 | -5.0% |
| Profit (loss) for the period before taxes | 9903 | -€48,865 | -€26,728 | +€22,137 | +45.3% |
| Profit (loss) for the period | 9904 | -€48,865 | -€26,728 | +€22,137 | +45.3% |
| Profit (loss) for the period to be appropriated | 9905 | -€48,865 | -€26,728 | +€22,137 | +45.3% |
Source: filed annual accounts (NBB), fiscal years ended 30 April 2024 and 30 April 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 September 2026 via checked.be.